Other, Other

Rapid regression of a bulky cranial lesion in high-risk multiple myeloma with isatuximab-based quadruplet induction.
Shun Ito; Takahiro Namiki; Hironao Nukariya; Toshihide Endo; Yoshihisa Sugawasa; Takashi Ichinohe; Kazuya Kurihara; Takashi Hamada; Shimon Otake; Hiromichi Takahashi; Hideki Nakamura; Shihoko Komine-Aizawa; Katsuhiro Miura
International journal of hematology, Apr. 2026

Frequency and clinical impact of acute kidney injury in haploidentical hematopoietic cell transplantation with post-transplantation cyclophosphamide.
Toshihide Endo; Hiromichi Takahashi; Takahiro Namiki; Yoshiyuki Hayashi; Shun Ito; Hironao Nukariya; Kazuya Kurihara; Takashi Koike; Yuuichi Takeuchi; Takashi Hamada; Kazuhide Iizuka; Shimon Otake; Masaru Nakagawa; Hideki Nakamura; Katsuhiro Miura
Leukemia research, Jan. 2026

[Venetoclax plus azacitidine as successful bridging therapy to second transplantation for post-transplant extramedullary relapse of acute myeloid leukemia].
Toshihide Endo; Hiromichi Takahashi; Takahiro Namiki; Yoshiyuki Hayashi; Shun Ito; Hironao Nukariya; Kazuya Kurihara; Takashi Koike; Takashi Hamada; Shimon Otake; Masaru Nakagawa; Hideki Nakamura; Katsuhiro Miura
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2026

[Achievement of a stringent complete response with low-dose pomalidomide monotherapy in a multiple myeloma patient].
Toshihide Endo; Takashi Hamada; Shimon Otake; Masaru Nakagawa; Yshihito Uchino; Hiromichi Takahashi; Katsuhiro Miura; Noriyoshi Iriyama; Takashi Koike; Kazuya Kurihara; Hiroko Sato; Yoshihiro Hatta; Msamai Takei
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2018